NOMAC-E2

DRUG6 trials

Sponsors

Organon and Co

Conditions

Contraception

Phase 3

Efficacy and Safety Study of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing DRSP/EE (292002)(P05722)

CompletedNCT00413062

Organon and CoContraception

Start: 2006-06-30End: 2008-08-31Updated: 2022-02-09

Effects on Ovarian Function of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing DRSP/EE (292003)(COMPLETED)(P05723)

CompletedNCT00511433

Organon and CoContraception

Start: 2006-10-31End: 2008-01-31Updated: 2022-02-09

Effects on Bone Mineral Density (BMD) of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing LNG/EE (292005)(P05765)(COMPLETED)

CompletedNCT00511342

Organon and CoContraception

Start: 2006-09-30End: 2009-06-30Updated: 2022-02-09

Effects on Hemostasis, Lipids, Carbohydrate Metabolism, Adrenal & Thyroid Function of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing LNG-EE (292004)(COMPLETED)(P05764)

CompletedNCT00511355

Organon and CoContraception

Start: 2006-10-31End: 2008-01-31Updated: 2022-02-09

Efficacy and Safety of the Combined Oral Contraceptive (COC) NOMAC-E2 Compared to a COC Containing DRSP/EE (292001)(COMPLETED)(P05724)

CompletedNCT00511199

Organon and CoContraception

Start: 2006-05-01End: 2008-04-01Updated: 2022-02-09

Study of the Contraceptive Efficacy and Safety of a NOMAC-E2 Combined Oral Contraceptive (COC)(P06448)

TerminatedNCT01656434

Organon and CoContraception

Start: 2012-11-02End: 2014-02-12Updated: 2024-06-20

Related Papers

Comparative analysis of the effects of nomegestrol acetate/17 β-estradiol and drospirenone/ethinylestradiol on premenstrual and menstrual symptoms and dysmenorrhea

The European Journal of Contraception & Reproductive Health Care2015-02-2534 citations

Efficacy, safety, and tolerability of a monophasic oral contraceptive containing nomegestrol acetate and 17β-estradiol: a randomized controlled trial.

2012-05-0139 citations